Hi Wombat,
Appreciate all your work.
The price per dose of 70k I think is very conservative, I think 100k to 150k is more realistic for US based on the costs that seem to be 500k-1,200k per stay for sever cases, Also for the people that don't make it, but would if given our treatment, that lost cost has to be factored in to the savings to the health funds. Not just the reduction in stay/cost for the ones that make it. Also the ongoing cost after an infection with all the complications in heart and other organs.
Speculative 8-month target - $33.00 MSB for GVHD, COVID ARDS, page-24
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.649B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $1.965M | 1.351M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 14287 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 7584 | 4 |
View Market Depth
| Last trade - 12.36pm 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |